Anti-claudin 1 antibodies for use in the treatment of colorectal cancer
US9931416B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 22, 2014 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Jul 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/734
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-claudin 1 antibodies for use in the treatment of colorectal cancer. In particular, the present invention relates to a method of treating a colorectal cancer in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an anti-claudin 1 (CLDN1) antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.